Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation.

DNA methylation circulating biomarkers epigenetics mesothelioma microRNA

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 01 10 2019
accepted: 13 03 2020
entrez: 23 4 2020
pubmed: 23 4 2020
medline: 23 4 2020
Statut: epublish

Résumé

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, which originates from the mesothelial cells of the pleura and is associated with asbestos exposure. In light of its aggressive nature, late diagnosis and dismal prognosis, there is an urgent need for identification of biomarkers in easily accessible samples (such as blood) for early diagnosis of MPM. In the last 10 years, epigenetic markers, such as DNA methylation and microRNAs (miRNAs), have gained popularity as possible early diagnostic and prognostic biomarkers in cancer research. The aim of this review is to provide a critical analysis of the current evidences on circulating epigenetic biomarkers for MPM and on their translational potential to the clinical practice for early diagnosis and for prognosis.

Identifiants

pubmed: 32318342
doi: 10.3389/fonc.2020.00445
pmc: PMC7146237
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

445

Informations de copyright

Copyright © 2020 Ferrari, Carugno, Mensi and Pesatori.

Références

Front Oncol. 2018 Apr 03;8:91
pubmed: 29666782
Reprod Toxicol. 2017 Mar;68:85-104
pubmed: 27421580
Cancers (Basel). 2018 Apr 01;10(4):
pubmed: 29614786
Int J Mol Sci. 2016 Oct 13;17(10):
pubmed: 27754357
Cancer Biomark. 2012;11(6):259-67
pubmed: 23248184
Adv Clin Chem. 2018;87:113-139
pubmed: 30342709
Dis Markers. 2017;2017:3510984
pubmed: 28348450
Clin Chem. 2015 Jan;61(1):56-63
pubmed: 25391989
Eur Respir Rev. 2015 Mar;24(135):115-31
pubmed: 25726562
PLoS One. 2014 Dec 03;9(12):e114483
pubmed: 25469901
Sci Rep. 2018 Sep 25;8(1):14321
pubmed: 30254313
Genes Chromosomes Cancer. 2018 Nov;57(11):573-583
pubmed: 30338612
Occup Environ Med. 2015 Sep;72(9):648-55
pubmed: 26045315
Oncotarget. 2016 Sep 6;7(36):58606-58637
pubmed: 27259231
Ann Transl Med. 2017 Jun;5(11):238
pubmed: 28706906
Lung Cancer. 2015 Dec;90(3):457-64
pubmed: 26431916
Cancer Causes Control. 2009 Oct;20(8):1237-54
pubmed: 19444627
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18066-71
pubmed: 23071320
Lung Cancer. 2013 Sep;81(3):311-318
pubmed: 23790315
JAMA Oncol. 2017 Jan 1;3(1):58-66
pubmed: 27584578
Lancet. 2004 Sep 25-Oct 1;364(9440):1157-66
pubmed: 15451223
Cancer Res. 2016 Jan 15;76(2):206-15
pubmed: 26719535
Clin Chem. 2015 Nov;61(11):1333-42
pubmed: 26408530
Biosci Trends. 2017 Mar 22;11(1):105-109
pubmed: 28133000
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Arch Pathol Lab Med. 2018 Jan;142(1):89-108
pubmed: 28686500
Int J Environ Res Public Health. 2018 May 16;15(5):
pubmed: 29772681
Front Genet. 2019 Mar 11;10:169
pubmed: 30915102
J Cell Biochem. 2019 Mar;120(3):3203-3211
pubmed: 30362153
J Thorac Dis. 2018 Jan;10(Suppl 2):S246-S252
pubmed: 29507792
Genes (Basel). 2019 Jan 09;10(1):
pubmed: 30634483
Nat Rev Genet. 2016 Jan;17(1):47-62
pubmed: 26666209
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
pubmed: 14973191
Expert Rev Respir Med. 2011 Oct;5(5):683-97
pubmed: 21955238
Environ Health Perspect. 2007 Oct;115(10):1401-5
pubmed: 17938727
Dis Markers. 2017;2017:9280170
pubmed: 28321148
Br J Biomed Sci. 2018 Apr;75(2):82-87
pubmed: 29452547
Clin Biochem. 2012 May;45(7-8):575-81
pubmed: 22374169
PLoS One. 2011 Apr 01;6(4):e18232
pubmed: 21483773
Front Genet. 2013 Jun 28;4:119
pubmed: 23825476
J Thorac Oncol. 2016 Feb;11(2):142-54
pubmed: 26811225
Transl Lung Cancer Res. 2017 Jun;6(3):350-365
pubmed: 28713680
Sci Rep. 2018 Jan 31;8(1):1949
pubmed: 29386530
Lung Cancer. 2017 May;107:65-72
pubmed: 27312601
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14128-33
pubmed: 16966607
Genes Chromosomes Cancer. 2018 Mar;57(3):123-139
pubmed: 29205637
Nat Genet. 2016 Apr;48(4):407-16
pubmed: 26928227
Mamm Genome. 2008 Aug;19(7-8):526-40
pubmed: 18636290
Scand J Work Environ Health. 2017 Nov 1;43(6):550-559
pubmed: 28985440
PLoS One. 2015 Aug 11;10(8):e0135331
pubmed: 26262875
BMC Res Notes. 2019 Feb 11;12(1):77
pubmed: 30744695
Surg Oncol. 2014 Sep;23(3):126-31
pubmed: 25031224
Cancer Treat Rev. 2014 Jun;40(5):648-55
pubmed: 24184333
Methods Mol Biol. 2015;1238:235-47
pubmed: 25421663
Expert Rev Mol Med. 2012 May 24;14:e12
pubmed: 22622048
Mol Cell Biochem. 2019 Apr;454(1-2):177-189
pubmed: 30357530
Rev Mal Respir. 2019 Feb;36(2):241-248
pubmed: 30686559
Neuropsychopharmacology. 2013 Jan;38(1):23-38
pubmed: 22781841
FASEB J. 2015 Sep;29(9):3853-62
pubmed: 26023181
Lung Cancer. 2006 Oct;54(1):109-16
pubmed: 16893590
Biomark Med. 2018 Feb;12(2):129-139
pubmed: 29338319
Oncotarget. 2016 Dec 13;7(50):82700-82711
pubmed: 27716620
PLoS One. 2013 Apr 23;8(4):e61253
pubmed: 23626673
Arch Pathol Lab Med. 2018 Jun;142(6):753-760
pubmed: 29480760
J Thorac Oncol. 2012 Jul;7(7):1184-91
pubmed: 22617246
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Carcinogenesis. 2013 Jul;34(7):1413-9
pubmed: 23677068
Transl Lung Cancer Res. 2017 Jun;6(3):259-269
pubmed: 28713671
Br J Cancer. 2016 Jun 14;114(12):1362-6
pubmed: 27228285
PLoS One. 2017 May 4;12(5):e0176680
pubmed: 28472171
Dis Markers. 2017;2017:9645940
pubmed: 28757678
Mol Cancer. 2019 Mar 30;18(1):59
pubmed: 30925927
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Noncoding RNA. 2019 Jun 17;5(2):
pubmed: 31212997
Ann Cardiothorac Surg. 2012 Nov;1(4):508-15
pubmed: 23977545
Oncotarget. 2017 Feb 21;8(8):13030-13038
pubmed: 28103581
Lung. 2016 Jun;194(3):409-17
pubmed: 27032653
J Thorac Oncol. 2016 Feb;11(2):249-55
pubmed: 26845118
Biochim Biophys Acta. 2014 Dec;1846(2):539-46
pubmed: 25444714
Lancet Oncol. 2009 May;10(5):453-4
pubmed: 19418618
Ann Transl Med. 2017 Jun;5(11):239
pubmed: 28706907
Mutat Res. 2019 Jul - Sep;781:1-10
pubmed: 31416570
Nature. 2017 Apr 26;545(7655):446-451
pubmed: 28445469
J Thorac Oncol. 2019 Mar;14(3):527-539
pubmed: 30408567
Lung. 2014 Feb;192(1):197-203
pubmed: 24170217
High Throughput. 2018 Jul 27;7(3):
pubmed: 30060501
Cancer Lett. 2016 Aug 10;378(2):120-30
pubmed: 27181379
Inhal Toxicol. 2010 Sep;22(11):937-62
pubmed: 20695727
Adv Clin Chem. 2010;52:145-67
pubmed: 21275343
Int J Cancer. 2009 Jan 1;124(1):201-7
pubmed: 18792097
PLoS One. 2012;7(1):e30221
pubmed: 22253921
Cell. 2002 Feb 22;108(4):439-51
pubmed: 11909516
Cell Prolif. 2019 May;52(3):e12589
pubmed: 30873683
PLoS One. 2013;8(3):e57841
pubmed: 23472110
Chest. 2002 Dec;122(6):2224-9
pubmed: 12475867
World J Clin Oncol. 2014 Oct 10;5(4):604-20
pubmed: 25302165
J Thorac Dis. 2018 Jan;10(Suppl 2):S237-S245
pubmed: 29507791
Carcinogenesis. 2019 Apr 29;40(2):246-253
pubmed: 30452625
Int J Cancer. 2007 Jan 15;120(2):215-23
pubmed: 17131333
Cancer Treat Rev. 2015 Jun;41(6):486-95
pubmed: 25979846
Cancer Sci. 2012 May;103(5):868-74
pubmed: 22321046
Epigenomics. 2011 Jun;3(3):267-77
pubmed: 22122337
Scand J Work Environ Health. 2015 Jan;41(1):5-15
pubmed: 25299403

Auteurs

Luca Ferrari (L)

EPIGET LAB, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

Michele Carugno (M)

EPIGET LAB, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Epidemiology Unit, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Carolina Mensi (C)

Epidemiology Unit, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Angela Cecilia Pesatori (AC)

EPIGET LAB, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Epidemiology Unit, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Classifications MeSH